Ocugen, Inc. — Director's Dealing 2021

Feb 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-01-29

Reporting Person: Subramanian Sanjay (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-29	Common Stock	M	35591	$0.51	Acquired	45591	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-29	Option (Right to Buy)	$0.510	M	35591	Disposed	2030-01-02	Common Stock (35591)	Direct

Footnotes

F1: Options to purchase one third of the shares (35,591 shares of common stock) vested on January 2, 2021. The remaining options will vest annually in equal installments on January 2, 2022 and January 2, 2023, subject to continued employment with the Company on the applicable vesting dates.